RxDoctor Payments DataLook up a doctor →

Arifulla Khan

Psychiatry · Bellevue, WANPI 1134241888

Payments from drug & device makers

$35,582,169in general payments, 2019–2025

Across 2,304 payments — averaging $15,444 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Eli Lilly$19.6M
  • AbbVie$4.4M
  • Sage Therapeutics, LLC$1.8M
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$1.6M
  • Pfizer$996K
  • Alkermes, Inc.$969K
  • plus $6.2M from 30 others
$315,420in research payments, 2019–2025

Across 58 payments — averaging $5438.28 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Eli Lilly$158K
  • Pfizer$152K
  • Eli Lilly Export S.A. Puerto Rico Branch$5K
  • Corcept Therapeutics$595

General payments by program year

19
22

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$35,582,169 in reported general payments places this provider in the 95th percentile of 576 psychiatry providers in Washington.

See all psychiatry providers in Washington

Other psychiatry in Bellevue

See the full list for Washington

Where these figures come from

Is this you, or does something look wrong? →